CHLOE TRUSTY: Open Payments
NPI 1053180794 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,963 in 54 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $1,978 · 2025 $1,963
Food & beverage: $1,963
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $254 |
| AstraZeneca Pharmaceuticals LP | 4 | $177 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $175 |
| ViiV Healthcare Company | 3 | $148 |
| ABBVIE INC. | 2 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $145 |
| Amgen Inc. | 1 | $132 |
| Hologic Sales and Service, LLC | 4 | $101 |
| Intra-Sana Laboratories | 2 | $100 |
| Exact Sciences Corporation | 3 | $75 |
Products named: XIFAXAN, APRETUDE, Ozempic, AIRSUPRA, QULIPTA, JARDIANCE, APTIMA, RELTONE 200 MG.
Industry payments across CA — which companies pay providers there.
